The Global Antifungal Drugs Market Is Expected To Witness High Growth Owing To the Increasing Prevalence of Fungal Infections in the World
Antifungal Drugs Market, by Drug Type (Echinocandins, Polyenes, Allylamines, Azoles, and Others), By Indication (Aspergillosis, Dermatophytosis, Candidiasis, Mucormycosis, and Others), By Dosage Form (Powders, Ointments, Drugs, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028.
The global antifungal drugs market is estimated to be valued at US$ 13.1 Bn in 2021 and is expected to exhibit a CAGR of 3.1% over the forecast period (2021-2028).
Market Overview:
Antifungal drugs are types of pharmaceutical chemistry designed to treat various fungal infections, including athlete’s foot, ringworm, and candidiasis. They can also be used to treat serious systemic infections such as mycosis. This type of drug is also known as an antimycotic medication and can help people who have serious fungal infection problems. Typically, antifungal drugs target a specific fungus. A plethora of natural ingredients can be found in the environment that can combat fungal infections. The azoles and echinocandins used against these fungi inhibit the synthesis of fungal cell walls, and echinocandins are a form of echinocandins. These compounds also inhibit the synthesis of yeast DNA/RNA, which is necessary for a fungal cell.
Request Here A Sample Copy of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/237
Competitive Landscape:
Major players operating in the global antifungal drugs market include Pfizer Inc, Novartis AG, Merck & Co. Inc., GlaxoSmithKline PLC, Glenmark, Astellas Pharma Inc., Bayer AG, and Abbott Laboratories.
Key Market Drivers:
The increasing incidence of fungal infection in the world is expected to drive the growth of the global antifungal drugs market. For instance, according to Global Action Fund for Fungal Infections, more than 300 million individuals suffer from critical fungal infections. There are many antifungal drugs available, but not all of them are effective. Some antifungal drugs can affect the heart or kidneys. Some of these can cause diarrhea, nausea, or even severe headaches. If patients are on medication for this condition, they need to be sure to speak with the healthcare provider to determine if it is right for them. It’s also important to note that some of these drugs only work against one type of fungus. Increasing product launches by key market players are estimated to create propulsion in the global antifungal drugs market.
Covid-19 Impact Analysis:
Increasing COVID-19 cases in the world is the main factor that negatively impacted the growth of the global antifungal drugs market, owing to the increasing incidence of COVID positive cases in the world, along with high requirements for medical attention towards COVID cases, which created negligence towards the other health treatments.
To get A Free PDF Brochure of This Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/237
Key Takeaways:
- The global antifungal drugs market is increased to grow at a CAGR of 3.5%, wooing to the increasing prevalence of fungal diseases in the world, along with new launches by key market players. For instance, in June 2021, Cadila Pharmaceuticals introduced Posaconazole, which is a new triazole antifungal drug.
- North America is expected to hold a major share of the global antifungal drugs market, owing to the increasing prevalence of fungal infections in the region. For instance, according to the U.S. Centers for Disease Control and Prevention, Aspergillus infection resulted in around 14,820 hospitalization cases in the world in the U.S. in 2020.
- The Asia Pacific is estimated to witness high growth in the global antifungal drugs market, owing to the increasing investment in the healthcare sector in the region, along with the high incidence of fungal issues among individuals.
To Direct Purchase this Premium Research Report: https://www.coherentmarketinsights.com/insight/buy-now/237
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Indication
- Market Snippet, By Dosage Form
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Regulatory Scenario
- PEST Analysis
- Recent Product Launch/Approval
- Epidemiology
- Diagnosis and Treatment Overview
- Competitive Intelligence
- Prescription Pattern
- Physicians Preferences and Views
- Market Dynamics
- Global Antifungal Drugs Market – Impact of Coronavirus (Covid-19) Pandemic
- Impact on Supply Chain
- Impact on Diagnosis and Treatment
- Impact on Research and Development
- Global Antifungal Drugs Market, By Drug Type, 2017-2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Echinocandins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Polyenes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Allylamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Azoles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Antifungal Drugs Market, By Indication, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Aspergillosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Dermatophytosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Candidiasis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Mucormycosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Antifungal Drugs Market, By Dosage Form, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Powders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Ointments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
Other Reports:
Gene and Cell Therapies Targeting CNS Disorders Market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837